StockMarketWire.com - RBC Capital Markets today reaffirms its sector performer investment rating on Circassia Pharmaceuticals Plc [LON:CIR] and cut its price target to 65p (from 81p).

Story provided by StockMarketWire.com

Broker Forecasts data provided by www.sharesmagazine.co.uk